Daniele Calistri

Biosciences Laboratory, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS

Affiliated withIstituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy

Research Area

Cancer Research

Biography

Daniele Calistri has not added Biography.
If you are Daniele Calistri and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 4	Year
Publication title Cited by 16	2017
Publication title Cited by 4	2017
Publication title	2018
Publication title Cited by 4	2020

Other Publications

Article	Year
Population-based screening for hereditary breast cancer in a region of North-Central Italy. International journal of molecular medicine\| PubMed ID: 12165804	2002
c-kit and SCF expression in normal and tumor breast tissue. Breast cancer research and treatment\| PubMed ID: 14997053	2004
Fecal multiple molecular tests to detect colorectal cancer in stool. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association\| PubMed ID: 15017656	2003
Urine telomerase: an important marker in the diagnosis of bladder cancer. Neoplasia (New York, N.Y.)\| PubMed ID: 15153335	2004
Detection of colorectal cancer by a quantitative fluorescence determination of DNA amplification in stool. Neoplasia (New York, N.Y.)\| PubMed ID: 15548362	2004
Mutation analysis of p53, K-ras, and BRAF genes in colorectal cancer progression. Journal of cellular physiology\| PubMed ID: 15702478	2005
Development and characterization of a monoclonal antibody directed against human telomerase reverse transcriptase (hTERT). Journal of biotechnology\| PubMed ID: 16046022	2005
p16INK4A and CDH13 hypermethylation in tumor and serum of non-small cell lung cancer patients. Journal of cellular physiology\| PubMed ID: 16222700	2006
Relevance of urine telomerase in the diagnosis of bladder cancer. JAMA\| PubMed ID: 16249419	2005
KRAS, p53 and BRAF gene mutations and aneuploidy in sporadic colorectal cancer progression. Cellular oncology : the official journal of the International Society for Cellular Oncology\| PubMed ID: 16988471	2006
Free DNA and carcinoembryonic antigen serum levels: an important combination for diagnosis of colorectal cancer. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 17145818	2006
[Telomerase activity: a molecular marker for early diagnosis of bladder tumor]. Recenti progressi in medicina\| PubMed ID: 17439065	2007
655Val and 1170Pro ERBB2 SNPs in familial breast cancer risk and BRCA1 alterations. Cellular oncology : the official journal of the International Society for Cellular Oncology\| PubMed ID: 17452776	2007
Urine telomerase activity for the detection of bladder cancer in females. The Journal of urology\| PubMed ID: 17574060	2007
Results of a population-based screening for hereditary breast cancer in a region of North-Central Italy: contribution of BRCA1/2 germ-line mutations. Breast cancer research and treatment\| PubMed ID: 18092194	2008
Disease family history and modification of breast cancer risk in common BRCA2 variants. Oncology reports\| PubMed ID: 18288416	2008
Quantitative fluorescence determination of long-fragment DNA in stool as a marker for the early detection of colorectal cancer. Cellular oncology : the official journal of the International Society for Cellular Oncology\| PubMed ID: 19096146	2009
The current role of telomerase in the diagnosis of bladder cancer. Indian journal of urology : IJU : journal of the Urological Society of India\| PubMed ID: 19468427	2009
The Integrated Oncology Program of the Italian Ministry of Health. Analytical and clinical validation of new biomarkers for early diagnosis: network, resources, methodology, quality control,... The International journal of biological markers\| PubMed ID: 19787622	2009
Accuracy of urine telomerase activity to detect bladder cancer in symptomatic patients. The International journal of biological markers\| PubMed ID: 20082275	2009
Fecal DNA for noninvasive diagnosis of colorectal cancer in immunochemical fecal occult blood test-positive individuals. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology\| PubMed ID: 20929882	2010
Bone metastases detection by circulating biomarkers: OPG and RANK-L. International journal of oncology\| PubMed ID: 21491082	2011
PI-PLCβ1 gene copy number alterations in breast cancer. Oncology reports\| PubMed ID: 22076473	2012
Genomic alterations in rectal tumors and response to neoadjuvant chemoradiotherapy: an exploratory study. Radiation oncology (London, England)\| PubMed ID: 22099067	2011
Predictive role of multiple gene alterations in response to cetuximab in metastatic colorectal cancer: a single center study. Journal of translational medicine\| PubMed ID: 22569004	2012
Urinary biomarkers of non-muscle-invasive bladder cancer: current status and future potential. Expert review of anticancer therapy\| PubMed ID: 22716491	2012
EGFR and K-ras mutations in cytologic samples from fine-needle aspirates in NSCLC patients. The European respiratory journal\| PubMed ID: 22753836	2012
LOH 19q indicates shorter disease progression-free interval in low-grade oligodendrogliomas with EMP3 methylation. Oncology reports\| PubMed ID: 22992787	2012
Urine cell-free DNA integrity as a marker for early bladder cancer diagnosis: preliminary data. Urologic oncology\| PubMed ID: 23141783	2013
Specific Biomarkers Are Associated with Docetaxeland Gemcitabine-Resistant NSCLC Cell Lines. Translational oncology\| PubMed ID: 23397475	2012
Urine cell-free DNA integrity as a marker for early prostate cancer diagnosis: a pilot study. BioMed research international\| PubMed ID: 23509700	2013
Molecular determinations of EGFR and EML4-ALK on a single slide of NSCLC tissue. Journal of clinical pathology\| PubMed ID: 23533259	2013
Gene methylation in rectal cancer: predictive marker of response to chemoradiotherapy? Journal of cellular physiology\| PubMed ID: 23702823	2013
DNA Methylation profiles as predictors of recurrence in non muscle invasive bladder cancer: an MS-MLPA approach. Journal of experimental & clinical cancer research : CR\| PubMed ID: 24252461	2013
Circulating and stool nucleic acid analysis for colorectal cancer diagnosis. World journal of gastroenterology\| PubMed ID: 24574768	2014
Target therapy in NSCLC patients: Relevant clinical agents and tumour molecular characterisation. Molecular and clinical oncology\| PubMed ID: 24649213	2013
Assessment of DNA damage and telomerase activity in exfoliated urinary cells as sensitive and noninvasive biomarkers for early diagnosis of bladder cancer in ex-workers of a rubber tyres ind... BioMed research international\| PubMed ID: 24877087	2014
First evidence of a large CHEK2 duplication involved in cancer predisposition in an Italian family with hereditary breast cancer. BMC cancer\| PubMed ID: 24986639	2014
Copy number analysis of 24 oncogenes: MDM4 identified as a putative marker for low recurrence risk in non muscle invasive bladder cancer. International journal of molecular sciences\| PubMed ID: 25026175	2014
Discrepancies between VEGF -1154 G>A polymorphism analysis performed in peripheral blood samples and FFPE tissue. International journal of molecular sciences\| PubMed ID: 25079441	2014
Promoter methylation of tumor suppressor genes in pre-neoplastic lesions; potential marker of disease recurrence. Journal of experimental & clinical cancer research : CR\| PubMed ID: 25091577	2014
Improved stool DNA integrity method for early colorectal cancer diagnosis. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology\| PubMed ID: 25128402	2014
Clinical and genetic factors related to cancer-induced bone pain and bone pain relief. The oncologist\| PubMed ID: 25342315	2014
Gene mutation analysis in EGFR wild type NSCLC responsive to erlotinib: are there features to guide patient selection? International journal of molecular sciences\| PubMed ID: 25561229	2014
EGFR methylation and outcome of patients with advanced colorectal cancer treated with cetuximab. Oncology letters\| PubMed ID: 25663927	2015
eNOS polymorphisms as predictors of efficacy of bevacizumab-based chemotherapy in metastatic colorectal cancer: data from a randomized clinical trial. Journal of translational medicine\| PubMed ID: 26259598	2015
Targeting Chromatin-Mediated Transcriptional Control of Gene Expression in Non-Small Cell Lung Cancer Therapy: Preclinical Rationale and Clinical Results. Drugs\| PubMed ID: 26347133	2015
Urine Cell-Free DNA Integrity Analysis for Early Detection of Prostate Cancer Patients. Disease markers\| PubMed ID: 26412928	2015
Nonsquamous, Non-Small-Cell Lung Cancer Patients Who Carry a Double Mutation of EGFR, EML4-ALK or KRAS: Frequency, Clinical-Pathological Characteristics, and Response to Therapy. Clinical lung cancer\| PubMed ID: 26712101	2016
Defining the cutoff value of MGMT gene promoter methylation and its predictive capacity in glioblastoma. Journal of neuro-oncology\| PubMed ID: 27029617	2016
Morphological and genetic heterogeneity in multifocal lung adenocarcinoma: The case of a never-smoker woman. Lung cancer (Amsterdam, Netherlands)\| PubMed ID: 27133750	2016
Circulating AR copy number and outcome to enzalutamide in docetaxel-treated metastatic castration-resistant prostate cancer. Oncotarget\| PubMed ID: 27191887	2016
miR-17-92a-1 cluster host gene (MIR17HG) evaluation and response to neoadjuvant chemoradiotherapy in rectal cancer. OncoTargets and therapy\| PubMed ID: 27226732	2016
Multiple primary tumors in a family with Li-Fraumeni syndrome with a TP53 germline mutation identified by next-generation sequencing. The International journal of biological markers\| PubMed ID: 27516001	2016
Methylation pattern analysis in prostate cancer tissue: identification of biomarkers using an MS-MLPA approach. Journal of translational medicine\| PubMed ID: 27576364	2016
GSTP1 Methylation and Protein Expression in Prostate Cancer: Diagnostic Implications. Disease markers\| PubMed ID: 27594734	2016
Impact of TP53 Mutations on Outcome in EGFR-Mutated Patients Treated with First-Line Tyrosine Kinase Inhibitors. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 27780855	2016
The potential use of urine cell free DNA as a marker for cancer. Expert review of molecular diagnostics\| PubMed ID: 27796148	2016
Cell-free DNA as a diagnostic marker for cancer: current insights. OncoTargets and therapy\| PubMed ID: 27822059	2016
Digital PCR identifies changes in CDH1 (E-cadherin) transcription pattern in intestinal-type gastric cancer. Oncotarget\| PubMed ID: 27861150	2016
What influences preneoplastic colorectal lesion recurrence? Oncotarget\| PubMed ID: 27902488	2016
Cell-free DNA detected by "liquid biopsy" as a potential prognostic biomarker in early breast cancer. Oncotarget\| PubMed ID: 28186965	2017
Multiple-gene panel analysis in a case series of 255 women with hereditary breast and ovarian cancer. Oncotarget\| PubMed ID: 28423363	2017
Right- vs. Left-Sided Metastatic Colorectal Cancer: Differences in Tumor Biology and Bevacizumab Efficacy. International journal of molecular sciences\| PubMed ID: 28598398	2017
Combined Inhibition of CDK4/6 and PI3K/AKT/mTOR Pathways Induces a Synergistic Anti-Tumor Effect in Malignant Pleural Mesothelioma Cells. Neoplasia (New York, N.Y.)\| PubMed ID: 28704762	2017
Circulating Plasma Levels of miR-20b, miR-29b and miR-155 as Predictors of Bevacizumab Efficacy in Patients with Metastatic Colorectal Cancer. International journal of molecular sciences\| PubMed ID: 29361687	2018
Stool DNA Integrity Method for Colorectal Cancer Detection. Methods in molecular biology (Clifton, N.J.)\| PubMed ID: 29589309	2018
Analysis of Genetic Alterations in Tunisian Patients with Lung Adenocarcinoma. Cells\| PubMed ID: 31141932	2019
E-cadherin Downregulation and microRNAs in Sporadic Intestinal-Type Gastric Cancer. International journal of molecular sciences\| PubMed ID: 31509966	2019
Multigene Panel Testing Increases the Number of Loci Associated with Gastric Cancer Predisposition. Cancers\| PubMed ID: 31514334	2019